苏州瑞徕生物科技

Suzhou Ruilai Biotechnology is a specialized molecular diagnostics company focused on the development of high-precision digital PCR (dPCR) technology. Headquartered in the Suzhou Industrial Park, the company integrates microfluidics, precision optics, and advanced biochemistry to create automated diagnostic platforms. Their flagship R-Lock digital PCR system provides absolute quantification of nucleic acids, offering superior sensitivity for liquid biopsy and rare mutation detection. Ruilai's product portfolio includes a range of diagnostic kits targeting oncology, infectious diseases, and reproductive health. By streamlining complex molecular workflows, the company aims to provide clinical laboratories with robust tools for precision medicine and personalized patient care.